Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy

被引:20
作者
Pearce, Andrew
Choo, Richard
Danjoux, Cyril
Morton, Gerard
Loblaw, D. Andrew
Szumacher, Ewa
Cheung, Patrick
Deboer, Gerrit
Chander, Sarat
机构
[1] Mayo Clin, Div Radiat Oncol, Rochester, MN 55905 USA
[2] Univ Calgary, Dept Radiat Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
[3] Univ Toronto, Dept Radiat Oncol, Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 01期
关键词
quality of life; recurrent prostate cancer; salvage radiotherapy; androgen suppression;
D O I
10.1016/j.ijrobp.2005.11.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To examine the effect of salvage radiotherapy (RT) plus 2-year androgen suppression (AS) on quality of life (QOL). Methods and Materials: A total of 74 patients with biopsy-proven local recurrence or PSA relapse after radical prostatectomy were treated with salvage RT plus 2-year AS, as per a phase 11 study. Quality of life was prospectively assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 30-Item Version 3.0 with the added prostate cancer-specific module at baseline and predefined follow-up visits. Results: Patients experienced a significant increase in bowel dysfunction (23%) by the end of RT (p < 0.0001). This bowel dysfunction improved after RT but remained slightly elevated (5-10%) throughout the 2-year AS period. This extent of residual bowel dysfunction would be considered of minimal clinical importance. A similar, but less pronounced, pattern of change did occur for urinary dysfunction. Erectile function showed no change during RT, but had an abrupt decline (10%) with initiation of AS that was of moderate clinical significance (p < 0.01). None of the other QOL domains demonstrated a persistent, significant change from baseline that would be considered of major clinical significance. Conclusion: The combined treatment with salvage RT plus 2-year AS had relatively minor long-term effects on QOL. (c) 2006 Elsevier Inc.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 15 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer [J].
Bacon, CG ;
Giovannucci, E ;
Testa, M ;
Kawachi, I .
JOURNAL OF UROLOGY, 2001, 166 (05) :1804-1810
[3]   SAFETY, SIDE-EFFECTS AND PATIENT ACCEPTANCE OF THE LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST LEUPROLIDE IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA [J].
ERI, LM ;
TVETER, KJ .
JOURNAL OF UROLOGY, 1994, 152 (02) :448-452
[4]  
FOSSA SD, 1997, EUR UROL S3, V3, P3
[5]   The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma [J].
Fowler, FJ ;
Collins, MM ;
Corkery, EW ;
Elliott, DB ;
Barry, MJ .
CANCER, 2002, 95 (02) :287-295
[6]   QUALITY-OF-LIFE - RADICAL PROSTATECTOMY VERSUS RADIATION-THERAPY FOR PROSTATE-CANCER [J].
LIM, AJ ;
BRANDON, AH ;
FIEDLER, J ;
BRICKMAN, AL ;
BOYER, CI ;
RAUB, WA ;
SOLOWAY, MS .
JOURNAL OF UROLOGY, 1995, 154 (04) :1420-1425
[7]   Health related quality of life in older men without prostate cancer [J].
Litwin, MS .
JOURNAL OF UROLOGY, 1999, 161 (04) :1180-1184
[8]   Recovery of health related quality of life in the year after radical prostatectomy: Early experience [J].
Litwin, MS ;
McGuigan, KA ;
Shpall, AI ;
Dhanani, N .
JOURNAL OF UROLOGY, 1999, 161 (02) :515-519
[9]   Quality of life following definitive therapy for localized prostate cancer: potential impact of multiple therapies [J].
Litwin, MS .
CURRENT OPINION IN UROLOGY, 2003, 13 (02) :153-156
[10]  
Lubeck DP, 2001, UROLOGY, V58, P94, DOI 10.1016/S0090-4295(01)01250-X